Literature DB >> 15289369

Troponin I isoform expression in human and experimental atrial fibrillation.

Victor L J L Thijssen1, Jannie Ausma, Luisa Gorza, Huub M W van der Velden, Maurits A Allessie, Isabelle C Van Gelder, Marcel Borgers, Guillaume J J M van Eys.   

Abstract

BACKGROUND: Atrial fibrillation (AF) is accompanied by re-expression of fetal genes and activation of proteolytic enzymes. In this study both aspects were addressed with respect to troponin I (TnI) isoform expression. METHODS AND
RESULTS: Western blotting and real-time reverse transcription-polymerase chain reaction were used to study TnI isoform expression in patients with paroxysmal or chronic AF and in goats after 1, 2, 4, 8, and 16 weeks of AF. In addition to cardiac TnI (cTnI), low expression of slow-twitch skeletal TnI (ssTnI) protein was found in 60% of patients in sinus rhythm or paroxysmal AF and in 8% of patients with chronic AF. In adult goat atrium, ssTnI protein expression was undetectable. Calcium-dependent degradation of cTnI protein was found in 1 or 2 of 6 animals after 1 to 4 weeks of AF. Although always low, ssTnI mRNA levels were significantly higher in patients who expressed ssTnI protein than in those who did not. Relative ssTnI mRNA expression was significantly lower in patients with paroxysmal AF and chronic AF than in those in sinus rhythm. In goats there was a tendency toward higher relative levels of ssTnI at the onset of AF followed by a normalization when AF had become sustained.
CONCLUSIONS: Atrial re-expression of ssTnI during paroxysmal AF in patients and during the first 2 weeks of pacing-induced AF in goats does not seem to be part of the process of AF-associated cardiomyocyte dedifferentiation but seems to result from transient cardiomyocyte stress at the onset of AF.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15289369     DOI: 10.1161/01.CIR.0000138849.03311.C6

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  6 in total

1.  Effects of thin and thick filament proteins on calcium binding and exchange with cardiac troponin C.

Authors:  Jonathan P Davis; Catalina Norman; Tomoyoshi Kobayashi; R John Solaro; Darl R Swartz; Svetlana B Tikunova
Journal:  Biophys J       Date:  2007-02-09       Impact factor: 4.033

2.  Protein Kinase 2β Is Expressed in Neural Crest-Derived Urinary Pacemaker Cells and Required for Pyeloureteric Contraction.

Authors:  Samir M Iskander; Meghan M Feeney; Kirby Yee; Norman D Rosenblum
Journal:  J Am Soc Nephrol       Date:  2018-02-07       Impact factor: 10.121

3.  Calmodulin kinase II-mediated sarcoplasmic reticulum Ca2+ leak promotes atrial fibrillation in mice.

Authors:  Mihail G Chelu; Satyam Sarma; Subeena Sood; Sufen Wang; Ralph J van Oort; Darlene G Skapura; Na Li; Marco Santonastasi; Frank Ulrich Müller; Wilhelm Schmitz; Ulrich Schotten; Mark E Anderson; Miguel Valderrábano; Dobromir Dobrev; Xander H T Wehrens
Journal:  J Clin Invest       Date:  2009-07       Impact factor: 14.808

4.  Disruption of protein kinase A interaction with A-kinase-anchoring proteins in the heart in vivo: effects on cardiac contractility, protein kinase A phosphorylation, and troponin I proteolysis.

Authors:  Bradley K McConnell; Zoran Popovic; Niladri Mal; Kwangdeok Lee; James Bautista; Farhad Forudi; Raul Schwartzman; J-P Jin; Marc Penn; Meredith Bond
Journal:  J Biol Chem       Date:  2008-10-21       Impact factor: 5.157

5.  Loss of proteostatic control as a substrate for atrial fibrillation: a novel target for upstream therapy by heat shock proteins.

Authors:  Roelien A M Meijering; Deli Zhang; Femke Hoogstra-Berends; Robert H Henning; Bianca J J M Brundel
Journal:  Front Physiol       Date:  2012-02-23       Impact factor: 4.566

6.  Physiological calcium combined with electrical pacing accelerates maturation of human engineered heart tissue.

Authors:  Shi Shen; Lorenzo R Sewanan; Stephanie Shao; Saiti S Halder; Paul Stankey; Xia Li; Stuart G Campbell
Journal:  Stem Cell Reports       Date:  2022-08-04       Impact factor: 7.294

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.